EQ
USDEquillium Inc. Common Stock
वास्तविक समय मूल्य
मूल्य चार्ट
मुख्य मीट्रिक्स
बाजार मीट्रिक्स
खुलना
$0.351
उच्च
$0.390
कम
$0.351
मात्रा
0.22M
कंपनी के मौलिक सिद्धांत
बाजार पूंजीकरण
13.8M
उद्योग
जैव प्रौद्योगिकी
देश
United States
ट्रेडिंग आँकड़े
औसत मात्रा
0.36M
एक्सचेंज
NCM
मुद्रा
USD
52-सप्ताह रेंज
संबंधित समाचार
Leerink Partners Downgrades Equillium to Market Perform, Lowers Price Target to $1
Leerink Partners analyst Thomas Smith downgrades Equillium from Outperform to Market Perform and lowers the price target from $3 to $1.
Equillium Announces Results of the Phase 3 EQUATOR Study of Itolizumab in First-Line Treatment of Patients with Acute Graft-Versus-Host Disease
Treatment with itolizumab did not improve complete or overall response rates at Day 29 Itolizumab achieved statistical significance in multiple secondary endpoints demonstrating compelling clinical benefit in
Equillium Reports Fourth Quarter and Full Year 2024 Financial Results and Recent Corporate and Clinical Highlights
Announced topline data from the Phase 3 EQUATOR study in first-line acute graft-versus-host disease Breakthrough Therapy designation and meeting request to discuss potential for Accelerated Approval submitted to FDA,
संबंधित स्टॉक
PFSI
PennyMac Financial Services Inc.
TVE
Tennessee Valley Authority
TBMCR
Trailblazer Merger Corporation I Rights
COFS
ChoiceOne Financial Services Inc.
ASND
Ascendis Pharma A/S American Depositary Shares
अपडेट रहें
मूल्य अलर्ट सेट करें, AI विश्लेषण अपडेट और वास्तविक समय बाजार समाचार प्राप्त करें।